224 related articles for article (PubMed ID: 16117784)
1. Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis.
Santiago B; Gutierrez-Cañas I; Dotor J; Palao G; Lasarte JJ; Ruiz J; Prieto J; Borrás-Cuesta F; Pablos JL
J Invest Dermatol; 2005 Sep; 125(3):450-5. PubMed ID: 16117784
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.
Hermida N; López B; González A; Dotor J; Lasarte JJ; Sarobe P; Borrás-Cuesta F; Díez J
Cardiovasc Res; 2009 Feb; 81(3):601-9. PubMed ID: 19019833
[TBL] [Abstract][Full Text] [Related]
3. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
[TBL] [Abstract][Full Text] [Related]
4. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis.
Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D
Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722
[TBL] [Abstract][Full Text] [Related]
5. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.
Baltanás A; Miguel-Carrasco JL; San José G; Cebrián C; Moreno MU; Dotor J; Borrás-Cuesta F; López B; González A; Díez J; Fortuño A; Zalba G
Antioxid Redox Signal; 2013 Nov; 19(14):1607-18. PubMed ID: 23350688
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
Luong VH; Chino T; Oyama N; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Biswas T; Hamasaki A; Fujita M; Okamoto Y; Otsuka M; Ihn H; Hasegawa M
Arthritis Res Ther; 2018 Mar; 20(1):46. PubMed ID: 29544542
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
9. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
[TBL] [Abstract][Full Text] [Related]
10. Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.
Shiota N; Kakizoe E; Shimoura K; Tanaka T; Okunishi H
Br J Pharmacol; 2005 Jun; 145(4):424-31. PubMed ID: 15806109
[TBL] [Abstract][Full Text] [Related]
11. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
Andreutti D; Gabbiani G; Neuville P
Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis.
Ide M; Jinnin M; Tomizawa Y; Wang Z; Kajihara I; Fukushima S; Hashizume Y; Asano Y; Ihn H
Exp Dermatol; 2017 Nov; 26(11):1139-1143. PubMed ID: 28418584
[TBL] [Abstract][Full Text] [Related]
14. Effect of P144® (Anti-TGF-β) in an "In Vivo" Human Hypertrophic Scar Model in Nude Mice.
Qiu SS; Dotor J; Hontanilla B
PLoS One; 2015; 10(12):e0144489. PubMed ID: 26720517
[TBL] [Abstract][Full Text] [Related]
15. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma.
Yamamoto T; Takagawa S; Katayama I; Nishioka K
Clin Immunol; 1999 Jul; 92(1):6-13. PubMed ID: 10413648
[TBL] [Abstract][Full Text] [Related]
16. CCN2 is required for bleomycin-induced skin fibrosis in mice.
Liu S; Shi-wen X; Abraham DJ; Leask A
Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.
Zarranz-Ventura J; Fernández-Robredo P; Recalde S; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
PLoS One; 2013; 8(5):e65434. PubMed ID: 23741494
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-'susceptible' mouse strains.
Oi M; Yamamoto T; Nishioka K
J Med Dent Sci; 2004 Mar; 51(1):7-17. PubMed ID: 15137460
[TBL] [Abstract][Full Text] [Related]
19. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
